NEOPLASMS BY SITE
Clinical trials for NEOPLASMS BY SITE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS BY SITE trials appear
Sign up with your email to follow new studies for NEOPLASMS BY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare kidney cancer: targeted drug shows promise in Late-Stage trial
Disease control OngoingThis study tests a new drug called savolitinib against a standard treatment (sunitinib) in people with a rare type of kidney cancer (papillary renal cell carcinoma) that has spread and cannot be removed by surgery. The cancer must have a specific genetic change (MET-driven). The …
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 01, 2026 15:41 UTC
-
New combo therapy shows promise for common lung cancer
Disease control OngoingThis study looks at how well a combination of osimertinib (a targeted drug) and chemotherapy works as the first treatment for people with advanced EGFR-mutant non-small cell lung cancer. About 532 adults with stage IIIB/IV or recurrent disease are being followed in real-world cli…
Matched conditions: NEOPLASMS BY SITE
Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
Robotic surgery vs radiation: which is better for throat cancer Patients' quality of life?
Symptom relief OngoingThis study compares two treatments for early-stage throat cancer: robotic surgery (TORS) and radiation therapy (IMRT). Researchers want to see which one leads to better swallowing function and overall quality of life. About 138 adults with HPV-related throat cancer are taking par…
Matched conditions: NEOPLASMS BY SITE
Phase: NA • Sponsor: Christian von Buchwald • Aim: Symptom relief
Last updated Apr 30, 2026 15:48 UTC